Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 4, 2013, Pages 504-508

  Efe, Cumali ^a   Wahlin, Staffan ^b   Ozaslan, Ersan ^c   Purnak, Tugrul ^c   Muratori, Luigi ^d   Quarneti, Chiara ^d   Tatar, Gonca ^a   Simsek, Halis ^a   Muratori, Paolo ^d   Schiano, Thomas D ^e  

^a HACETTEPE UNIVERSITY   (Turkey)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Numune Research and Education Hospital ^*  (Turkey)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Auto antibody; Autoimmune hepatitis; Hepatitis B; Hepatitis C; Overlap syndrome; Revised criteria; Simplified criteria

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ITALY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SWEDEN; TURKEY (BIRD); UNITED STATES;

ADULT; AGED; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITALY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME; TURKEY; UNITED STATES;

EID: 84875459649     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.772231     Document Type: Article

References (15)

1. Krawitt EL. Autoimmune hepatitis. N Engl JMed 2006;354: 54-66.
2. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
3. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76.
4. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008;48:1540-8.
5. Schiano TD, Te HS, Thomas RM, Hussain H, Bond K, Black M. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol 2001;96:2984-91.
6. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-213.
7. Bedossa P, Poynard T; for the METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
8. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011; 31:30-60.
9. Toy M, Onder FO, Wörmann T, Bozdayi AM, Schalm SW, Borsboom GJ, et al. Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis 2011; 11:337.
10. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996;125:588-98.
11. Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci 2011; 56:545-54.
12. Chrétien P, Chousterman M, Abd Alsamad I, Ozenne V, Rosa I, Barrault C, et al. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun 2009;32:201-5.
13. Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-32.
14. Badiani RG, Becker V, Perez RM, Matos CA, Lemos LB, Lanzoni VP, et al. Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis? World J Gastroenterol 2010;16:3704-8.
15. Calvaruso V, Craxì A. 2011 European Association of the study of the liver hepatitis C virus clinical practice guidelines. Liver Int 2012;32:2-8.